Meyers Primary Care Institute, Worcester, Massachusetts, USA.
Drugs Aging. 2010 Dec 1;27(12):999-1008. doi: 10.2165/11584790-000000000-00000.
Osteoporosis is a significant health problem, especially for older women. Prescription osteoporosis medication can reduce fractures, but many women do not accept treatment or discontinue treatment before benefits are achieved.
To explore older women's views about prescription osteoporosis medication use in depth and to identify specific beliefs and experiences that influence these views.
We conducted in-depth telephone interviews with women aged ≥65 years with clinically confirmed osteoporosis. Interviewees were asked about their beliefs and experiences related to osteoporosis and osteoporosis treatment. Interviews were recorded and transcribed; key themes were identified using qualitative analysis.
Perceived need, medication effectiveness and medication safety were identified as critical influences on women's views about prescription osteoporosis medication. These perceptions were in turn influenced by various beliefs, experiences and behaviours, including interactions with the physician, personal experience and behaviours, and vicarious experience.
Older women with osteoporosis need clear information about their condition, including the diagnosis, the implications of the diagnosis, treatment options, medication effectiveness and side effects. Physicians should check with their patients to confirm understanding and address concerns, as older women may not always voice their reservations and concerns.
骨质疏松症是一个严重的健康问题，尤其是老年女性。处方骨质疏松药物可以减少骨折，但许多女性在获益之前不接受治疗或停止治疗。
深入探讨老年女性对处方骨质疏松药物使用的看法，并确定影响这些看法的具体信念和经验。
我们对年龄≥65 岁且经临床确诊患有骨质疏松症的女性进行了深入的电话访谈。受访者被问及与骨质疏松症和骨质疏松症治疗相关的信念和经验。采访进行了录音并转录；使用定性分析确定了关键主题。
认为有必要、药物有效性和药物安全性被确定为影响女性对处方骨质疏松药物看法的关键因素。这些看法反过来又受到各种信念、经验和行为的影响，包括与医生的互动、个人经验和行为以及间接经验。
患有骨质疏松症的老年女性需要了解有关其病情的明确信息，包括诊断、诊断的影响、治疗选择、药物有效性和副作用。医生应与患者核对以确认其理解并解决顾虑，因为老年女性可能并不总是表达其保留意见和担忧。
